Alight and Socially Determined Sign a Multi-year Agreement to Transform Employee Wellbeing Through Comprehensive Social Risk Data and Analytics

The agreement provides Alight with exclusive access to the leading social determinants of health dataset in the market to better serve Alight’s clients LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital and technology services provider, and Socially Determined, a social risk data and analytics company that empowers organizations to manage risk and … [Read more…]

Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes

K-757 and K-833 are first in a new class of oral agents, known as nutrient receptor agonists, that target the body’s natural physiology to secrete appetite-suppressing hormones NEW YORK–(BUSINESS WIRE)–Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced the initiation of their … [Read more…]

PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer

BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced the appointment of Robert Lyne as Chief Portfolio Officer. Robert brings a decade of experience in international life science deals and portfolio management, along with governance and … [Read more…]

Prospection Appoints Technology-industry Veteran and Commercialization Leader Daniel West to Chief Executive Officer

Prospection Board of Directors strengthens software-as-a-service and life sciences expertise with additions of Craig Jones and Bruce Goodwin SYDNEY–(BUSINESS WIRE)–#PCI—Prospection – the pioneer of patient-centric intelligence – today announced software-as-a-service (SaaS) and go-to-market (GTM) seasoned executive, Daniel West, as Chief Executive Officer (CEO). Prospection also brings deep technology- and pharmaceutical-industry experience to its Board of … [Read more…]

Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid’s original investor … [Read more…]

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

— Conference Call Today at 5:00 p.m. Eastern Time — SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year ended June 30, 2023. “Over just the next few quarters we look forward to data readouts from two ongoing clinical … [Read more…]

AHF Opens State-of-the-Art HIV Healthcare Center on Capitol Hill

Patient-centered model allows for utmost discretion and one-to-one care; Site also features full-service AHF Pharmacy and free STI testing and treatment WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) is opening a new, state-of-the-art Healthcare Center on Capitol Hill Wednesday to continue delivering cutting-edge medical care and services to patients regardless of insurance status or ability to pay. … [Read more…]

SYNAPS Dx Observes September as World Alzheimer’s Month and Healthy Aging Month: Celebrates Researchers, Providers and Patients

ROCKLAND, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes September as World Alzheimer’s Month and Healthy Aging Month to advocate for the accurate identification of AD, implement proactive risk reduction measures to delay and prevent the onset of AD … [Read more…]

Bristol Myers Squibb to Report Results for Third Quarter 2023 on October 26, 2023

PRINCETON, N.J.–(BUSINESS WIRE)–$bmy #bristolmyerssquibb—Bristol Myers Squibb (NYSE: BMY) will announce results for the third quarter of 2023 on Thursday, October 26, 2023. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date. Investors and the general public are invited … [Read more…]